29/05/2026
We are incredibly proud to have received the 2026 American Chamber of Commerce Ireland Global Impact Award at the US-Ireland Business Awards last night.
This award recognises organisations whose work is delivering meaningful impact internationally, and we are honoured that Aerogen Solo was recognised for demonstrating how Irish engineering, manufacturing excellence, and talent, when combined with US clinical adoption, education, and partnership, can improve patient care at a global scale.
Developed and manufactured in Ireland, the Aerogen Solo is now used in over 80 countries worldwide and has supported the treatment of more than 30 million patients. Its adoption across the United States, including 95% of the top 1,000 hospitals, is a testament to the strength of the long-standing relationship between Ireland and the US, and what can be achieved when innovation and collaboration come together with a shared purpose: improving lives.
Great to hear Michael Lohan, CEO of IDA Ireland, announce this year’s winner and speak about
teams based in Ireland that not only support global operations but shape them.
Thank you again to AmCham for this incredible honour, and to our colleagues, customers, clinicians, and partners around the world who make achievements like this possible every day.
